A Bank’s Lawsuit Threatens to Unwind the Braskem Control Sale
Markets
Key Facts
—The move. Banco Safra has asked a São Paulo court to suspend the sale of control of Braskem to an IG4-backed fund.
—The claim. Safra is a creditor owed about $105 million and argues the deal wrongly shields the buyer from inherited debts.
—The argument. The bank says debt-free transfers apply only to competitive auctions, not to a direct sale to a pre-chosen buyer.
—The stakes. Braskem carries roughly $7.5 billion in net debt and is Latin America’s largest petrochemical maker.
—The ripple. A win for Safra could make it far harder for distressed Brazilian firms to sell strategic assets quickly.
The Braskem control sale looked all but done. Now a single creditor bank has gone to court to try to unwind it, and its argument could unsettle far more than one deal.
Banco Safra filed an appeal at São Paulo’s bankruptcy court. It asked a judge to suspend the transfer of Braskem control to a fund advised by the private-equity firm IG4 Capital.
The bank is a creditor of the petrochemical maker. The sum at stake for Safra is about 560 million reais, roughly $105 million.
But the bank’s real challenge is to the legal structure of the whole deal. It reaches beyond just its own claim.
Why the Braskem control sale is being challenged
The heart of the fight is a mechanism that shields a buyer from a seller’s old debts. That protection lets a fund buy a distressed asset clean, without inheriting hidden or legacy liabilities.
That clean transfer is what makes such assets attractive at all. Safra argues the shield applies only to sales run as competitive auctions.
Braskem’s control was sold directly to a pre-chosen buyer. So the bank says the debt-free treatment should not apply here.
If a judge agrees, the fund could be forced to take on part of the seller’s liabilities. That would blow a hole in the financial design of a deal built to avoid exactly that.
Safra also attacks how the price was set. It says the value of control was found by simply multiplying the average share price by the number of shares.
That method, the bank says, ignores the control premium that Brazilian corporate law contemplates. The seller, Novonor, the renamed Odebrecht, has hit back hard.
It calls the move opportunistic and argues Safra has no standing. The bank was not among the lenders whose Braskem-backed loans were folded into the transaction.
A precedent that reaches beyond one company
This is why the case matters well beyond Braskem. If the court accepts Safra’s reasoning, the ruling would make direct, negotiated rescues of troubled companies much riskier for buyers.
Distressed-asset funds hunt for cheap companies precisely because they can buy them free of legacy claims. Strip away that certainty and the appetite to inject capital into companies in crisis could quickly cool.
The timing sharpens the point. The same IG4 is pursuing a similar creditor-debt play to take control of the fuel group Raízen, one of Brazil’s largest corporate rescues, using the very mechanics Safra now questions.
Braskem itself has little room to spare. It ended last year with about $7.5 billion in net debt.
The new owners have been preparing an out-of-court restructuring. That is instead of a fresh injection of cash.
For a foreign investor, the episode is a window into how Brazil’s debt crunch is reshaping ownership. Specialist funds are quietly taking over strained companies, and the courts are now being asked where the limits of that game lie.
Nothing is settled yet. The judge has still to rule on the request to suspend the transfer, and the wider market for corporate rescues will be watching the São Paulo court closely.
The backdrop is one of Latin America’s longest corporate sagas. Braskem was the last major asset of Odebrecht, the conglomerate brought down by the sprawling Car Wash corruption scandal.
Its sale was meant to close that chapter for good. The structure that finally broke the impasse was itself novel.
Rather than buy shares on the market, IG4 gathered up bank debt backed by Braskem stock. It then converted that into control, sharing the company with the state oil firm Petrobras.
Live Company IntelligenceBraskem S.A — the full investor dossier
Valuation & profitability
Price & risk
$4.7052-wk high
$13.78
Revenue trend · 6y
Ownership
Dividend
Frequently Asked Questions
What is the Braskem control sale dispute about?
Banco Safra, a creditor owed about $105 million, has asked a São Paulo court to suspend the transfer of Braskem’s control to an IG4-backed fund. It argues the deal wrongly shields the buyer from inherited debts because it was a direct sale rather than a competitive auction.
Why does the Braskem control sale matter for other companies?
If the court sides with Safra, it could set a precedent that debt-free transfers do not apply to direct sales. That would make it harder and riskier for funds to buy strategic assets from distressed Brazilian firms quickly.
Connected Coverage
Brazil’s Braskem moves to skip bond payments as a new owner takes control
Braskem asks creditors for time as the chemical giant fights on
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error
LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.
Read More from The Rio Times